Stoke Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Stoke Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2020 to Q3 2024.
  • Stoke Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 597 %, a 33.8% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 597 -304 -33.8% Sep 30, 2024
Q2 2024 687 -215 -23.9% Jun 30, 2024
Q1 2024 780 -115 -12.8% Mar 31, 2024
Q4 2023 879 -117 -11.8% Dec 31, 2023
Q3 2023 901 -228 -20.2% Sep 30, 2023
Q2 2023 903 -441 -32.8% Jun 30, 2023
Q1 2023 895 -835 -48.3% Mar 31, 2023
Q4 2022 997 -1.33K -57.2% Dec 31, 2022
Q3 2022 1.13K -1.73K -60.5% Sep 30, 2022
Q2 2022 1.34K -1.81K -57.4% Jun 30, 2022
Q1 2022 1.73K -1.5K -46.4% Mar 31, 2022
Q4 2021 2.33K -765 -24.7% Dec 31, 2021
Q3 2021 2.86K -958 -25.1% Sep 30, 2021
Q2 2021 3.16K -1.2K -27.6% Jun 30, 2021
Q1 2021 3.23K -1.56K -32.6% Mar 31, 2021
Q4 2020 3.1K Dec 31, 2020
Q3 2020 3.81K Sep 30, 2020
Q2 2020 4.36K Jun 30, 2020
Q1 2020 4.78K Mar 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.